Table 1.
Function of the primary cell types implicated in SSc pathogenesis both in the blood circulation and at the site of fibrosis.
Cell Type | Function |
---|---|
Endothelial cell | Platelet adhesion activates fibrotic pathways. Increased microvascular permeability causes leukocyte adhesion to the endothelium, leading to increased inflammation [7]. |
Monocyte/Macrophage | A prominent M2 macrophage signature increases levels of pro-fibrotic cytokines such as IL-4, IL-6, and IL-13 and correlates with elevated tissue fibrosis [17,18,19,20]. |
Eosinophil | Elevated eosinophil counts in the peripheral blood are associated with severe lung disease and presence of skin ulcers [31,32,33]. |
Mast cell | Release of cytokines and growth factors such as IL-4, IL-6, IL-13, TNF-a, PDGF, and TGF-β activates myofibroblasts to produce collagen [37]. Tryptase and histamine release triggers fibroblast proliferation [38,39]. |
Innate lymphoid cell | Increased production of the ILC2 cytokines IL-25, IL-33, and TSLP in serum and skin mediates fibrosis in a TGF-β-dependent manner [43,44,45,46,47,48,49]. |
Plasmacytoid dendritic cell | Elevated numbers of CXCL4+- and IFN-a-producing pDCs in skin and lungs are involved in increased fibrotic manifestations mediated by TLR8 activation [28,50,52]. |
T lymphocyte | Skin is predominantly infiltrated by CD4+ and CD8+ cytotoxic T cells that produce pro-fibrotic cytokines and cause apoptosis to epithelial cells [6,72]. Increased IL-21-producing Tph cells promote plasmablast differentiation and increase activation of myofibroblasts [75,77]. In the peripheral blood, SSc patients are characterized by increased Th2 and Th17 numbers compared to healthy donors [4,60,63]. |
B lymphocyte | Elevated BAFF and APRIL are correlated with skin thickening [81,83]. Increased IL-6-producing Beffs increase inflammation, while decreased IL-10-producing Bregs exhibit a reduced capacity for immunosuppression [82]. In SSc peripheral blood, an increase in naïve and a decrease in activated memory B cells is observed compared to healthy controls [4,85,87,91]. |